5Abdelmeguid AE,Topol EJ,Whitlow PL,et al.Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions[J].Circulation,1996,94:1528-1536.
6Brener SJ,Ellis SG,Schneider J,et al.Frequency and long-term impact of myonecrosis after coronary stenting[J].Eur Heart J,2002,23:869-876.
7Stone GW,Mehran R,Dangas G,et al.Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention:a device-specific analysis of 7 147 patients[J].Circulation,2001,104:642-647.
8Saucedo JF,Mehran R,Dangas G,et al.Long-term clinical events following creatine kinase-myocardial band isoenzyme elevation after successful coronary stenting[J].J Am Coll Cardiol,2000,35:1134-1141.
9Briguoria C,Colombob A,Airoldi F,et al.Statin administration before percutaneous coronary intervention:impact on periprocedural myocardial infarction[J].Eur Heart J,2004,25:1822-1828.
10Pasceri V,Patti G,Nusca A,et al.Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention:results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study[J].Circulation,2004,110:674-678.
8Bahrmann P,Werner GS,Heusch G,et al.Detection of coronary microembolization by Doppler ultrasound in patients with stable angina pectoris undergoing elective percutaneous coronary interventions.Circulation,2007,115 (5):600-608.
9Chew DP,Bhatt DL,Robbins MA,et al.Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention.Circulation,2001,104(9):992-997.
10Heusch G,Schulz R,Erbel R.Inflammatory markers in coronary heart disease:coronary vascular versus myocardial origin? Circulation,2003,108(1):e4.
